Deborah L Nucatola

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Depo-medroxyprogesterone acetate (DMPA) is an effective injectable contraceptive with worldwide availability. However, it is associated with a high incidence of breakthrough bleeding (BTB) during the first 6 months of use which often leads to discontinuation. Mifepristone is a progesterone receptor antagonist that has been demonstrated to decrease BTB(More)
  • 1